270 related articles for article (PubMed ID: 23059543)
1. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines.
Ihmaid S; Al-Rawi J; Bradley C; Angove MJ; Robertson MN; Clark RL
Bioorg Med Chem; 2011 Jul; 19(13):3983-94. PubMed ID: 21664823
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structural elucidation and DNA-dependant protein kinase and antiplatelet studies of 2-amino-[5, 6, 7, 8-mono and 7, 8-di-substituted]-1,3-benzoxazines.
Ihmaid S; Al-Rawi J; Bradley C
Eur J Med Chem; 2010 Nov; 45(11):4934-46. PubMed ID: 20800933
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione.
Morrison R; Al-Rawi JM
J Enzyme Inhib Med Chem; 2016; 31(sup2):86-95. PubMed ID: 27255290
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 8-aryl-2-morpholino-7-O-substituted benzo[e][1,3]oxazin-4-ones against DNA-PK, PI3K, PDE3A enzymes and platelet aggregation.
Saifuzzaman M; Morrison R; Zheng Z; Orive S; Hamilton J; Thompson PE; Al-Rawi JMA
Bioorg Med Chem; 2017 Oct; 25(20):5531-5536. PubMed ID: 28838830
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
Pritchard KM; Al-Rawi J; Bradley C
Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines.
Morrison R; Al-Rawi JM; Jennings IG; Thompson PE; Angove MJ
Eur J Med Chem; 2016 Mar; 110():326-39. PubMed ID: 26854431
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of linear and angular aryl-morpholino-naphth-oxazines, their DNA-PK, PI3K, PDE3A and antiplatelet activity.
Morrison R; Zheng Z; Jennings IG; Thompson PE; Al-Rawi JMA
Bioorg Med Chem Lett; 2016 Nov; 26(22):5534-5538. PubMed ID: 27765510
[TBL] [Abstract][Full Text] [Related]
10. The synthesis of 4,7-disubstituted-2H-benzo[b][1,4]-oxazin-3(4H)-ones using Smiles rearrangement and their in vitro evaluation as platelet aggregation inhibitors.
Xia S; Liu JQ; Wang XH; Tian Y; Wang Y; Wang JH; Fang L; Zuo H
Bioorg Med Chem Lett; 2014 Mar; 24(6):1479-83. PubMed ID: 24565904
[TBL] [Abstract][Full Text] [Related]
11. Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
Hollick JJ; Rigoreau LJ; Cano-Soumillac C; Cockcroft X; Curtin NJ; Frigerio M; Golding BT; Guiard S; Hardcastle IR; Hickson I; Hummersone MG; Menear KA; Martin NM; Matthews I; Newell DR; Ord R; Richardson CJ; Smith GC; Griffin RJ
J Med Chem; 2007 Apr; 50(8):1958-72. PubMed ID: 17371003
[TBL] [Abstract][Full Text] [Related]
12. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
[TBL] [Abstract][Full Text] [Related]
13. DNA-dependent protein kinase (DNA-PK) inhibitors: structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain.
Clapham KM; Bardos J; Finlay MR; Golding BT; Griffen EJ; Griffin RJ; Hardcastle IR; Menear KA; Ting A; Turner P; Young GL; Cano C
Bioorg Med Chem Lett; 2011 Feb; 21(3):966-70. PubMed ID: 21216595
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study.
Anderluh M; Cesar J; Stefanic P; Kikelj D; Janes D; Murn J; Nadrah K; Tominc M; Addicks E; Giannis A; Stegnar M; Dolenc MS
Eur J Med Chem; 2005 Jan; 40(1):25-49. PubMed ID: 15642407
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
[TBL] [Abstract][Full Text] [Related]
16. Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffold.
Ilić M; Kikelj D; Ilaš J
Eur J Med Chem; 2012 Apr; 50():255-63. PubMed ID: 22365562
[TBL] [Abstract][Full Text] [Related]
17. 1,4-Benzoxazine-3(4H)-ones as potent inhibitors of platelet aggregation: design, synthesis and structure-activity relations.
Liu C; Tan JL; Xiao SY; Liao JF; Zou GR; Ai XX; Chen JB; Xiang Y; Yang Q; Zuo H
Chem Pharm Bull (Tokyo); 2014; 62(9):915-20. PubMed ID: 25007750
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides.
Liu XJ; Shi XX; Zhong YL; Liu N; Liu K
Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
